These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17380778)

  • 1. [Placebo effect in Parkinson's disease].
    Miwa H
    Brain Nerve; 2007 Feb; 59(2):139-46. PubMed ID: 17380778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.
    Quattrone A; Barbagallo G; Cerasa A; Stoessl AJ
    Mov Disord; 2018 Aug; 33(8):1213-1227. PubMed ID: 30230624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Great expectations: the placebo effect in Parkinson's disease.
    Lidstone SC
    Handb Exp Pharmacol; 2014; 225():139-47. PubMed ID: 25304530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
    Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
    Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo mechanisms and reward circuitry: clues from Parkinson's disease.
    de la Fuente-Fernández R; Schulzer M; Stoessl AJ
    Biol Psychiatry; 2004 Jul; 56(2):67-71. PubMed ID: 15231437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans.
    Hilker R; Voges J; Ghaemi M; Lehrke R; Rudolf J; Koulousakis A; Herholz K; Wienhard K; Sturm V; Heiss WD
    Mov Disord; 2003 Jan; 18(1):41-8. PubMed ID: 12518299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor and cognitive placebo-/nocebo-responses in Parkinson's disease patients with deep brain stimulation.
    Keitel A; Wojtecki L; Hirschmann J; Hartmann CJ; Ferrea S; Südmeyer M; Schnitzler A
    Behav Brain Res; 2013 Aug; 250():199-205. PubMed ID: 23651878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo responses in Parkinson's disease.
    Lou JS
    Int Rev Neurobiol; 2020; 153():187-211. PubMed ID: 32563288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Ruth TJ; Sossi V; Schulzer M; Calne DB; Stoessl AJ
    Science; 2001 Aug; 293(5532):1164-6. PubMed ID: 11498597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.
    Strafella AP; Ko JH; Monchi O
    Neuroimage; 2006 Jul; 31(4):1666-72. PubMed ID: 16545582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Stoessl AJ
    Trends Neurosci; 2002 Jun; 25(6):302-6. PubMed ID: 12086748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.
    Frisaldi E; Carlino E; Lanotte M; Lopiano L; Benedetti F
    Cortex; 2014 Nov; 60():3-9. PubMed ID: 24457096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Parkinson's disease STN stimulation enhances responsiveness of movement initiation speed to high reward value.
    Kojovic M; Higgins A; Jahanshahi M
    Neuropsychologia; 2016 Aug; 89():273-280. PubMed ID: 27371365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine release in human ventral striatum and expectation of reward.
    de la Fuente-Fernández R; Phillips AG; Zamburlini M; Sossi V; Calne DB; Ruth TJ; Stoessl AJ
    Behav Brain Res; 2002 Nov; 136(2):359-63. PubMed ID: 12429397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo effect and dopamine release.
    de la Fuente-Fernández R; Lidstone S; Stoessl AJ
    J Neural Transm Suppl; 2006; (70):415-8. PubMed ID: 17017561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.